Ikarian Capital »

Newamsterdam Pharma Co Nv shares owned by Ikarian Capital

Quarter-by-quarter ownership of Newamsterdam Pharma Co Nv (NAMS) shares owned by Ikarian Capital from 13F filings

Historical chart of Ikarian Capital investment in Newamsterdam Pharma Co Nv

Tip: Access up to 7 years of quarterly data

All positions including Newamsterdam Pharma Co Nv held by Ikarian Capital consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Newamsterdam Pharma Co Nv by Ikarian Capital

Quarter filed Position value Share count Share price at filing
2025-09-30 $3.0M 107k 28.44
2025-06-30 $3.7M 207k 18.11
2024-09-30 $483k 29k 16.60

More positions owned by Ikarian Capital

United Therapeutics Corporation Put Option (UTHR)
Spdr Series Trust S&p Biotech Put Option (XBI)
Genmab A/s Sponsored Ads (GMAB)
Bristol Myers Squibb Put Option (BMY)
Abivax Sa Sponsored Ads (ABVX)
Uniqure Nv Call Call Option
Insmed Com Par $.01 (INSM)
Ptc Therapeutics I (PTCT)
Ionis Pharmaceuticals (IONS)
Cidara Therapeutics Com New (CDTX)
Scholar Rock Hldg Corp Put Option (SRRK)
Rapt Therapeutics Com New (RAPT)
Maze Therapeatics (MAZE)
Soleno Therapeutics (SLNO)
Cytokinetics Com New (CYTK)

View all positions for Ikarian Capital

Top funds holding Newamsterdam Pharma Co Nv

Frazier Life Sciences Management
Bain Capital Life Sciences Investors
RA Capital Management
Capital World Investors
Fcpm Iii Services B.v.
Viking Global Investors
FMR
Deerfield Management Company
Jennison Associates
Wellington Management Company
Polar Capital Holdings
Medicxi Ventures Management
Adage Capital Partners GP
Cormorant Asset Management
Alliancebernstein

View all funds holding Newamsterdam Pharma Co Nv